Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology
Cover of the book Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease by , Humana Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781592597246
Publisher: Humana Press Publication: March 4, 1999
Imprint: Humana Language: English
Author:
ISBN: 9781592597246
Publisher: Humana Press
Publication: March 4, 1999
Imprint: Humana
Language: English

In Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, the major investigators working in this rapidly advancing field join together under the aegis of A. Michael Lincoff and Eric J. Topol to provide the first comprehensive overview of the preclinical and clinical development of the glycoprotein IIb/IIIa receptor antagonists. These acknowledged experts elucidate the theoretical basis for the inhibition of platelet aggregation in the treatment of coronary syndromes, present and synthesize evidence for the efficacy of glycoprotein IIb/IIIa blockade in inhibiting ischemic complications of both coronary intervention and acute coronary syndromes, and provide guidelines for the use of this novel class of agents in the clinical management of cardiovascular disease. They also compare the pharmacology and clinical efficacy of the currently available glycoprotein IIb/IIIa receptor inhibitors and speculate about further potential applications of these agents in the treatment of vascular disease.
Written by the scientists and physicians who discovered and characterized this important new class of receptors, invented the first IIb/IIIa agents, and conducted the definitive clinical trials, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease offers the most complete and authoritative review of these powerful new therapeutics available today.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, the major investigators working in this rapidly advancing field join together under the aegis of A. Michael Lincoff and Eric J. Topol to provide the first comprehensive overview of the preclinical and clinical development of the glycoprotein IIb/IIIa receptor antagonists. These acknowledged experts elucidate the theoretical basis for the inhibition of platelet aggregation in the treatment of coronary syndromes, present and synthesize evidence for the efficacy of glycoprotein IIb/IIIa blockade in inhibiting ischemic complications of both coronary intervention and acute coronary syndromes, and provide guidelines for the use of this novel class of agents in the clinical management of cardiovascular disease. They also compare the pharmacology and clinical efficacy of the currently available glycoprotein IIb/IIIa receptor inhibitors and speculate about further potential applications of these agents in the treatment of vascular disease.
Written by the scientists and physicians who discovered and characterized this important new class of receptors, invented the first IIb/IIIa agents, and conducted the definitive clinical trials, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease offers the most complete and authoritative review of these powerful new therapeutics available today.

More books from Humana Press

Cover of the book Diabetes & C-Peptide by
Cover of the book Adult and Embryonic Stem Cells by
Cover of the book Pharmacotherapy of Depression by
Cover of the book Babelandia by
Cover of the book Targeted Therapies by
Cover of the book Endocrinology of Breast Cancer by
Cover of the book Neoplastic Hematopathology by
Cover of the book Essential Urologic Laparoscopy by
Cover of the book Brain Hypoxia and Ischemia by
Cover of the book Diseases of the Gastroesophageal Mucosa by
Cover of the book Biology and Management of Multiple Myeloma by
Cover of the book Diseases of the Thyroid by
Cover of the book Evidence-Based Medical Ethics: by
Cover of the book Immunosuppression and Human Malignancy by
Cover of the book Handbook of Drug-Nutrient Interactions by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy